The 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU)
ASCO GU 2025 Prostate Cancer
ASCO GU 2025 Bladder Cancer
ASCO GU 2025 Kidney Cancer
ASCO GU 2025 Upper Tract Urothelial Carcinoma
ASCO GU 2025 Penile, Urethral, Testicular, and Adrenal Cancers
ASCO GU 2025 Press Releases
- First Real-World Outcomes Data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be Presented at 2025 ASCO Genitourinary Cancers Symposium
- Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium
- Bayer Unveils Latest Data from Prostate Cancer Portfolio at 2025 ASCO GU Cancers Symposium
- Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)
- Mobile Prostate Cancer Screening Clinic Can Help Address Barriers to Serving High-Risk Communities